NCT00583544View on ClinicalTrials.gov

A Safety and Tolerability Single Ascending Dose Study in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

January 31, 2008

Study Completion Date

February 29, 2008

Conditions
Healthy
Interventions
DRUG

TC-2216

Multiple ascending dose groups will be explored.

Trial Locations (1)

Unknown

Forenap Pharma, Rouffache

All Listed Sponsors
lead

Targacept Inc.

INDUSTRY

NCT00583544 - A Safety and Tolerability Single Ascending Dose Study in Healthy Volunteers | Biotech Hunter | Biotech Hunter